

Long-Term Benefit for T+A in Liver Cancer confirmed with CHIEF data - Beyond the Trial
Liver Cancer Podcast di International Liver Cancer Association (ILCA)
S3 · E10
15 mag 2026
17:12
Note sull'episodio
Season 3 - Episode 10
In this episode, Dr. Manon Allaire, a physician at La Pitié-Salpêtrière Hospital in Paris, shares her perspective on evolving approaches in liver cancer care. Using the CHIEF data as a starting point, the discussion looks beyond the trial to reflect on how emerging evidence is interpreted in clinical practice. Dr. Allaire offers a thoughtful overview of key considerations, ongoing questions, and what these discussions may mean for the future of treatment.
Parole chiave
liver cancer
clinical trials
hcc
systemic therapy
cell biology
hepatocellular carcinoma